<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Boyle NR</submitter><funding>NIA NIH HHS</funding><funding>NINDS NIH HHS</funding><pagination>107024</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12320091</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>213</volume><pubmed_abstract>Loss-of-function mutations affecting the lysosomal protein progranulin are a leading cause of frontotemporal dementia. Progranulin mutations cause abnormalities in lysosomal lipid processing, particularly of sphingolipids, major components of neural cell membranes that play important signaling roles in the brain. Most work in this area has focused on two classes of sphingolipids, gangliosides and cerebrosides. Here, we examined enzymes involved in metabolism of another class of sphingolipids, the sphingomyelins, in both mouse models and patients with progranulin insufficiency. Acidic sphingomyelinase activity was decreased in progranulin knockout, but not heterozygous, mice. This resulted from post-transcriptional loss of acid sphingomyelinase (Smpd1) protein. Progranulin interacted with a</pubmed_abstract><journal>Neurobiology of disease</journal><pubmed_title>Reduction of sphingomyelinase activity associated with progranulin deficiency and frontotemporal dementia.</pubmed_title><pmcid>PMC12320091</pmcid><funding_grant_id>K00 AG068428</funding_grant_id><funding_grant_id>P30 AG086401</funding_grant_id><funding_grant_id>P30 AG062422</funding_grant_id><funding_grant_id>P01 AG019724</funding_grant_id><funding_grant_id>R00 AG056597</funding_grant_id><funding_grant_id>RF1 AG079318</funding_grant_id><funding_grant_id>F30 AG071114</funding_grant_id><funding_grant_id>R01 NS105971</funding_grant_id><pubmed_authors>Miller BL</pubmed_authors><pubmed_authors>Nana AL</pubmed_authors><pubmed_authors>Boyle NR</pubmed_authors><pubmed_authors>Grinberg LT</pubmed_authors><pubmed_authors>Tadepalli AS</pubmed_authors><pubmed_authors>Ramos EM</pubmed_authors><pubmed_authors>Fox SN</pubmed_authors><pubmed_authors>Arrant AE</pubmed_authors><pubmed_authors>Roberson ED</pubmed_authors><pubmed_authors>Kukar T</pubmed_authors><pubmed_authors>Spina S</pubmed_authors><pubmed_authors>Seyfried NT</pubmed_authors><pubmed_authors>Seeley WW</pubmed_authors></additional><is_claimable>false</is_claimable><name>Reduction of sphingomyelinase activity associated with progranulin deficiency and frontotemporal dementia.</name><description>Loss-of-function mutations affecting the lysosomal protein progranulin are a leading cause of frontotemporal dementia. Progranulin mutations cause abnormalities in lysosomal lipid processing, particularly of sphingolipids, major components of neural cell membranes that play important signaling roles in the brain. Most work in this area has focused on two classes of sphingolipids, gangliosides and cerebrosides. Here, we examined enzymes involved in metabolism of another class of sphingolipids, the sphingomyelins, in both mouse models and patients with progranulin insufficiency. Acidic sphingomyelinase activity was decreased in progranulin knockout, but not heterozygous, mice. This resulted from post-transcriptional loss of acid sphingomyelinase (Smpd1) protein. Progranulin interacted with a</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-03-31T11:56:19.043Z</modification><creation>2025-09-01T03:08:24.347Z</creation></dates><accession>S-EPMC12320091</accession><cross_references><pubmed>40633679</pubmed><doi>10.1016/j.nbd.2025.107024</doi></cross_references></HashMap>